These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28874421)

  • 1. Combination Therapy to Target Reperfusion Injury After ST-Segment-Elevation Myocardial Infarction: A More Effective Approach to Cardioprotection.
    Hausenloy DJ; Yellon DM
    Circulation; 2017 Sep; 136(10):904-906. PubMed ID: 28874421
    [No Abstract]   [Full Text] [Related]  

  • 2. Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]).
    Pasupathy S; Tavella R; Grover S; Raman B; Procter NEK; Du YT; Mahadavan G; Stafford I; Heresztyn T; Holmes A; Zeitz C; Arstall M; Selvanayagam J; Horowitz JD; Beltrame JF
    Circulation; 2017 Sep; 136(10):894-903. PubMed ID: 28634219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ischemic postconditioning during primary percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: A single-center cross-sectional study.
    Mukherjee P; Jain M
    Ann Card Anaesth; 2019; 22(4):347-352. PubMed ID: 31621667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating HtrA2 after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A potential novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury.
    Hortmann M; Robinson S; Mohr M; Haenel D; Mauler M; Laumann R; Stallmann D; Reinoehl J; Duerschmied D; Peter K; Bode C; Ahrens I
    Int J Cardiol; 2017 Dec; 249():437. PubMed ID: 29121749
    [No Abstract]   [Full Text] [Related]  

  • 5. Apoptosis kinetics at reperfusion period in patients with acute ST-Segment Elevation Myocardial Infarction undergoing primary percutaneous coronary intervention and treated with thrombolytic therapy.
    Gultekin N; Bulut G; Kucukates E; Yildiz A; Kocas C; Bulut L
    J Pak Med Assoc; 2016 Jul; 66(7):808-14. PubMed ID: 27427127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide as a predictor of ischemia/reperfusion injury immediately after myocardial reperfusion in patients with ST-segment elevation acute myocardial infarction.
    Arakawa K; Himeno H; Kirigaya J; Otomo F; Matsushita K; Nakahashi H; Shimizu S; Nitta M; Takamizawa T; Yano H; Endo M; Kanna M; Kimura K; Umemura S
    Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):62-70. PubMed ID: 25609593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction.
    Hortmann M; Robinson S; Mohr M; Haenel D; Mauler M; Stallmann D; Reinoehl J; Duerschmied D; Peter K; Bode C; Ahrens I
    Int J Cardiol; 2017 Sep; 243():485-491. PubMed ID: 28602551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter by Ye et al Regarding Article, "Early Use of
    Ye Z; Su Q; Li L
    Circulation; 2018 Mar; 137(13):1422-1423. PubMed ID: 29581374
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter by Mansour et al Regarding Article, "Early Use of N-Acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [
    Mansour A; Le Breton H; Auffret V
    Circulation; 2018 Mar; 137(13):1420-1421. PubMed ID: 29581373
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter by Khan and Boyle Regarding Article, "Early Use of N-Acetylcysteine (NAC) With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Reduces Myocardial Infarct Size (The NACIAM Trial [
    Khan AA; Boyle AJ
    Circulation; 2018 Mar; 137(13):1418-1419. PubMed ID: 29581372
    [No Abstract]   [Full Text] [Related]  

  • 11. Response by Pasupathy et al to Letters Regarding Article, "Early Use of N-acetylcysteine (NAC) With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Reduces Myocardial Infarct Size (The NACIAM Trial [
    Pasupathy S; Tavella R; Beltrame JF
    Circulation; 2018 Mar; 137(13):1424-1425. PubMed ID: 29581375
    [No Abstract]   [Full Text] [Related]  

  • 12. Reperfusion Treatment in Late Presentation Acute Myocardial Infarction.
    Alkhalil M; Choudhury RP
    Circ Cardiovasc Interv; 2018 Sep; 11(9):e007287. PubMed ID: 30354604
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Mandurino-Mirizzi A; Crimi G; Raineri C; Pica S; Ruffinazzi M; Gianni U; Repetto A; Ferlini M; Marinoni B; Leonardi S; De Servi S; Oltrona Visconti L; De Ferrari GM; Ferrario M
    J Cardiovasc Med (Hagerstown); 2018 May; 19(5):240-246. PubMed ID: 29470249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of comprehensive remote ischemic conditioning in anterior ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Design and rationale of the CORIC-MI randomized trial.
    Song L; Yan H; Zhou P; Zhao H; Liu C; Sheng Z; Tan Y; Yi C; Li J; Zhou J
    Clin Cardiol; 2018 Aug; 41(8):997-1003. PubMed ID: 29726013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015.
    Puymirat E; Simon T; Cayla G; Cottin Y; Elbaz M; Coste P; Lemesle G; Motreff P; Popovic B; Khalife K; Labèque JN; Perret T; Le Ray C; Orion L; Jouve B; Blanchard D; Peycher P; Silvain J; Steg PG; Goldstein P; Guéret P; Belle L; Aissaoui N; Ferrières J; Schiele F; Danchin N;
    Circulation; 2017 Nov; 136(20):1908-1919. PubMed ID: 28844989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid Biomarkers in Acute Myocardial Infarction Before and After Percutaneous Coronary Intervention by Lipidomics Analysis.
    Feng L; Yang J; Liu W; Wang Q; Wang H; Shi L; Fu L; Xu Q; Wang B; Li T
    Med Sci Monit; 2018 Jun; 24():4175-4182. PubMed ID: 29913478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection from Reperfusion Injury with Intracoronary N-Acetylcysteine in Patients with STEMI Undergoing Primary Percutaneous Coronary Intervention in a Cardiac Tertiary Center.
    Nozari Y; Eshraghi A; Talasaz AH; Bahremand M; Salamzadeh J; Salarifar M; Pourhosseini H; Jalali A; Mortazavi SH
    Am J Cardiovasc Drugs; 2018 Jun; 18(3):213-221. PubMed ID: 29322434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editor's Choice- Pathophysiology and therapy of myocardial ischaemia/reperfusion syndrome.
    Rossello X; Lobo-Gonzalez M; Ibanez B
    Eur Heart J Acute Cardiovasc Care; 2019 Aug; 8(5):443-456. PubMed ID: 31172789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.